The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPIX.L Regulatory News (PPIX)

  • There is currently no data for PPIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

27 Oct 2011 07:00

RNS Number : 9193Q
ProPhotonix Limited
27 October 2011
 



 

27 October 2011

 

ProPhotonix Limited

 ("ProPhotonix" or "the Company")

 

THIRD QUARTER AND YEAR-TO-DATE RESULTS

 

Improved financial performance on 16% revenue increase

 

ProPhotonix Limited, (London Stock Exchange - AIM: PPIX and PPIR, OTC: STKR.PK), a designer and manufacturer of LED light engines and laser diodes modules with operations in Ireland and the U.K., today announces its financial results for the third quarter and year-to-date September 30, 2011.

 

Year-to-Date 2011:

·; Revenue increased 22% to $13.5 million ( 2010: $11.0 million), up 16% adjusting for impact of currency fluctuation

·; LED revenue increased 41% to $6.9 million ( 2010: $4.9 million)

·; Gross profit increased 24.4% to $5.2 million (2010: $4.2 million)

·; Gross profit margin improved to 38.9% (2010: 38.0%)

·; EBITDA of $0.5 million vs. $0.2 million loss in 2010 (excluding AIM flotation expenses and facility lease termination charges)

·; Order bookings of $13.9 million

·; Percentage revenue by market sectors: industrial 74%, medical 17%, and homeland security & defense 9%

·; Percentage revenue by geography: 57% Europe, 33% North America and 10% Rest of World

 Third Quarter 2011:

·; Revenue increased by 16% to $4.5 million (Q3 2010: $3.9 million), up 10% adjusting for impact of currency fluctuation

·; LED revenue increased 16% to $2.2 million (Q3 2010: $1.9 million)

·; Gross profit increased 13.5% to $1.8 million (Q3 2010: $1.6 million)

·; Gross profit margin 38.9% (Q3 2010: 39.9%)

·; EBITDA of $0.2 million vs. break-even, net of AIM expenses in 2010

·; Order bookings of $4.4 million; ending backlog of $6.1 million

·; Percentage revenue by market sectors: industrial 75%, medical 14%, and homeland security & defense 11%

·; Percentage revenue by geography: 55% Europe, 34% North America and 11% Rest of World

·; Raised $5.1 million (£3.3million), through the placement of new common shares at $0.22 (14 pence) per share with institutional investors

 

Commenting on the results, Mark W. Blodgett, Chairman & CEO of ProPhotonix, said: "We delivered a strong third quarter with 16% revenue growth, despite the negative impact from foreign currency exchange due to the strengthening of the dollar in September, and a delay in shipments to two medical customers.

 

Several milestones were met during the quarter including reaching breakeven operating profitability and a significant improvement in EBITDA profitability. Third quarter EBITDA was approximately $200,000, which was net of $60,000 of recruitment fees for new US sales personnel hired at the end of the quarter and $50,000 of reserve provisions."

 

  

Enquiries:

 

ProPhotonix Limited

Mark W. Blodgett, CEO

 

Tel: +44 (0)12 7971 7170

ir@prophotonix.com

Brewin Dolphin Limited

Neil Baldwin / James White

 

Tel: +44 (0)113 241 0130

Cubitt Consulting

Chris Lane / Alice Coubrough

Tel: +44 (0) 20 7367 5100

 

 

RD:IR

Isabel Richardson

Tel: +44 (0) 20 7492 0500

 

 

About ProPhotonix

ProPhotonix Limited, headquartered in Salem, New Hampshire, is an independent designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Opnext, QSI, Sanyo, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, defense, sensors, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

 

 

 

Year-to-Date 2011 Financial Results

 

Total year-to-date revenue in 2011 was $13.5 million, an increase of 22% (16%, adjusting for currency fluctuation) compared with $11.0 million in 2010. Gross profit was $5.2 million, an increase of 24% compared to $4.2 million in 2010. Gross profit margin increased to 38.9% from 38% in 2010 due to higher volumes, a more favorable product mix, and productivity improvement initiatives. Foreign currency exchange impact on gross profit margin was $0.2 million.

 

Operating expenses, excluding intangible amortization, totaled $5.2 million versus $5.2 million, net of approximately $0.8 million of charges related to the London Stock Exchange AIM flotation and a facility lease termination charge. The operating loss was $0.2 million, as compared to $1.3 million loss in 2010, excluding the AIM flotation expenses and facility lease termination charges. EBITDA was $0.5 million versus a 2010 Adjusted EBITDA loss of $0.2 million which excludes the AIM flotation expenses and facility lease termination charges. Net loss was $0.6 million including tax provision of $0.1 million in 2011 and compares to the 2010 net loss of $2.8 million, which includes a loss on sale of discontinued operations in the amount of $0.1 million and a loss from discontinued operations in the amount of $0.1 million, as well as the AIM flotation expenses and facility lease termination charges of $0.8 million.

 

Third Quarter 2011 Financial Results

 

Total revenue for the third quarter of 2011 of $4.5 million increased 16% (up 10%, adjusting for currency fluctuation) from Q3 2010. Revenue growth came from increases in the Company's LED segment of $0.3 million (+16%) and its laser segment of approximately $0.3 million (+16%) over last year. The impact of foreign currency exchange year-on-year was approximately $0.2 million. Bookings for the third quarter of 2011 were $4.4 million and the order backlog was $6.1 million at September 30, 2011.

Gross profit was $1.8 million for Q3 2011, an increase of 14% compared to $1.6 million in Q3 2010. Q3 gross profit margin was 38.9% compared with 39.9% in the comparable quarter in 2010. Foreign currency exchange favorably impacted gross profit margin by approximately 0.1%.

 

Operating expenses, excluding intangible amortization, totaled $1.7 million, a decrease of 5% compared to the $1.8 million in Q3 2010, net of AIM flotation expenses of $0.2 million. Selling expenses increased approximately 5%; R&D expenses increased approximately 43%, offset by administration expenses, which decreased by approximately 17%, net of the AIM flotation expenses of $0.2 million. The company achieved break-even at the operating level in Q3 2011 as compared to an operating loss of $0.3 million for the third quarter 2010, net of the AIM flotation expenses of $0.2 million in 2010.

 

EBITDA of $0.2 million for the quarter compares to a break-even Adjusted EBITDA for Q3 2010, net of the AIM expenses. The net loss of $0.1 million compares to the 2010 net loss of $0.5 million, which includes a loss from discontinued operations of approximately $17,000, as well as the AIM flotation expenses of $0.2 million.

 

 

Outlook

 

The Company continues to exhibit significant improvement in its overall financial performance, as compared to last year, benefiting from continuing revenue growth in both its laser and LED systems businesses. Profitability continues to improve, driven by improved productivity in both Cork and Stansted facilities and ongoing vigilant cost management, particularly with regard to G&A expenditures. During the third quarter, the Company significantly increased its North American sales force, including a new sales manager and is in the process of selectively adding to its R&D team, adding medical product management expertise and augmenting its European sales force. Finally, the Company is in the process of adding distribution channels in both Korea and Taiwan, to complement the recent appointment of Luster LightTech, China's leading distributor of machine vision products. ProPhotonix continues to benefit from growth in the medical, solar and home land security markets, and with these proposed investments we look to expand our customer base in Europe, US and Asia.

 

 

 

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without limitation, those with respect to ProPhotonix's goals, plans and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: uncertainty that cash balances may not be sufficient to allow ProPhotonix to meet all of its business goals; uncertainty that ProPhotonix's new products will gain market acceptance; the risk that delays and unanticipated expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk that one of our competitors could develop and bring to market a technology that is superior to those products that we are currently developing; and ProPhotonix's ability to capitalize on its significant research and development efforts by successfully marketing those products that the Company develops. Forward-looking statements represent management's current expectations and are inherently uncertain. All Company, brand, and product names are trademarks or registered trademarks of their respective holders. ProPhotonix undertakes no duty to update any of these forward-looking statements.

 

 

 

Use of Non-GAAP Financial Measures

 

The Company provides non-GAAP financial measures, such as EBITDA, to complement its consolidated financial statements presented in accordance with GAAP. Non-GAAP financial measures do not have any standardized definition and, therefore, are unlikely to be comparable to similar measures presented by other reporting companies. These non-GAAP financial measures are intended to supplement the user's overall understanding of the Company's current financial and operating performance and its prospects for the future. Specifically, the Company believes the non-GAAP results provide useful information to both management and investors by identifying certain expenses, gains and losses that, when excluded from the GAAP results, may provide additional understanding of the Company's core operating results or business performance, which management uses to evaluate financial performance for purposes of planning for future periods. However, these non-GAAP financial measures are not intended to supersede or replace the Company's GAAP results.

 

The Company uses EBITDA (earnings before interest, taxes, depreciation, amortization, stock-based compensation and impairment charges) as a non-GAAP financial measure in this press release. A reconciliation of EBITDA to net loss for the third quarter and year-to-date 2011 is as follows:

 

 

Three Months Ended

Nine Months Ended

($ in thousands)

(Unaudited)

September 30,

2011

2010

2011

2010

Net Loss

$(85)

$(454)

$(567)

$(2,755)

Loss on sale of discontinued operations

-

-

-

58

Loss from discontinued operations

-

17

19

126

Plus:

Interest and other expense/(income), net

32

(125)

229

293

Depreciation

80

131

247

379

Intangible asset amortization

75

99

231

294

Stock based compensation

55

125

203

407

Taxes

46

(46)

119

(111)

Amortization of debt discount & financing costs

-

86

-

279

EBITDA Profit / (Loss)

203

(167)

481

(1,030)

 

AIM listing expenses

-

194

-

705

Facility lease termination charge

-

-

-

115

 

Adjusted EBITDA Profit (Loss)

$203

$27

$481

$(210)

 

Consolidated Statements of Operations

(Unaudited)

($ In thousands except share and per share data)

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

2011

2010

2011

2010

Net Revenue

$4,537

$3,899

$13,451

$11,046

Cost of Revenue

2,773

2,345

8,222

6,843

Gross Profit

1,764

1,554

5,229

4,203

Research & Development Expenses

230

161

703

517

Selling, General & Administrative Expenses

1,466

1,816

4,495

5,502

Amortization of Intangible Assets

75

99

231

294

Operating Loss

(7)

(522)

(200)

(2,110)

Interest Income & Other Income

58

237

52

145

Amortization of Debt Discount and Financing Costs

-

(86)

-

(279)

Interest Expense

(90)

(112)

(281)

(438)

Loss Before Taxes from Continuing Operations

(39)

(483)

(429)

(2,682)

Tax Provision (Benefit)

46

(46)

119

(111)

Net Loss from Continuing Operations

(85)

(437)

(548)

(2,571)

Loss on Sale of Discontinued Operations, net of tax

-

-

-

(58)

Loss from Discontinued Operations, net of tax

-

(17)

(19)

(126)

Net Loss

$(85)

$(454)

$(567)

$(2,755)

Loss Per Share:

Basic and diluted net loss per share from continuing operations

($0.00)

($0.01)

($0.01)

($0.06)

Basic and diluted net loss per share from loss on sale of discontinued operations

$0.00

$0.00

$0.00

($0.00)

Basic and diluted net loss per share from discontinued operations

$0.00

($0.00)

($0.00)

($0.00)

Basic and diluted net loss per share

$(0.00)

($0.01)

($0.01)

($0.06)

Basic and diluted weighted average shares outstanding

73,008,577

44,407,504

59,306,576

44,253,622

FINANCIAL STATEMENTS

PROPHOTONIX LIMITED

CONSOLIDATED BALANCE SHEETS

(unaudited)

 ($ in Thousands except share and per share data)

 

As of September 30, 2011 and December 31, 2010

 

2011

 

2010

 

Assets

Current assets:

Cash and cash equivalents

$ 5,385

$ 1,811

Accounts receivable, less allowances of $22 in 2011 and $47 in 2010

2,380

1,957

Inventories

1,751

1,892

Prepaid expenses and other current assets

245

295

 

 

Total current assets

9,761

5,955

Net property, plant and equipment

749

906

Goodwill

480

468

Acquired intangible assets, net

393

610

Other long-term assets

107

66

 

 

Total assets

$ 11,490 

$ 8,005

 

 

Liabilities and Stockholders' Equity (Deficit)

Current liabilities:

Revolving credit facility

$ 872

$ 641

Current portion of long-term debt

800

600

Capital lease obligations

2

24

Accounts payable

1,378

2,003

Income taxes payable

114

-

Accrued expenses

1,040

1,368

 

 

Total current liabilities

4,206

4,636

Long-term debt, net of current portion

2,825

3,407

Other long-term liabilities

178

150

 

 

Total liabilities

7,209

8,193

Stockholders' equity (deficit):

Common stock, par value $0.001; shares authorized 150,000,000 at September 30, 2011 and 100,000,000 at December 31, 2010; 76,060,174 shares issued and outstanding at September 30, 2011 and 52,510,174 shares issued and outstanding at December 31, 2010

76

53

Paid-in capital

110,755

105,678

Accumulated deficit

(106,742 )

(106,175 )

Accumulated other comprehensive income

192

256

 

 

Total stockholders' equity (deficit)

4,281

(188)

 

 

Total liabilities and stockholders' equity (deficit)

$ 11,490

$ 8,005

 

 

 

PROPHOTONIX LIMITED

CONSOLIDATED STATEMENTS OF CASH FLOWS

In thousands

(unaudited)

 

Periods Ended September 30

 

2011

 

2010

 

Operations

Net loss

$ (567)

$ (2,755)

Loss from discontinued operations, net of tax

(19)

(126)

Loss on sale of discontinued operations, net of tax

-

(58)

 

 

Loss from continuing operations

(548)

(2,571)

 

 

Adjustments to reconcile net loss to net cash used in operating activities:

Stock-based compensation expense

203

407

Depreciation and amortization

478

673

Amortization of debt discount and financing costs

-

279

Non cash interest income

-

(4)

Provision for inventories

67

33

(Gain) loss on disposal of assets

1

(2)

Provision for bad debts

-

37

Deferred taxes

-

(111)

Other change in assets and liabilities:

Accounts receivable

(418)

(904)

Inventories

123

(748)

Prepaid expenses and other current assets

54

220

Accounts payable

(680)

886

Income taxes payable

119

-

Accrued expenses

(348)

243

Other assets and liabilities

(2)

-

 

 

Net cash used in continuing operations

(951 )

(1,562 )

Net cash used in discontinued operations

(19)

(184)

 

 

Net cash used in operating activities

(970 )

(1,746 )

 

 

Investing

Proceeds from disposal of assets

-

3

Financing obligation payments

-

(109 )

Purchase of property, plant and equipment

(75 )

(187 )

 

 

Net cash used in investing activities

(75)

(293)

 

 

Financing

Net proceeds from sale of common stock

4,897

-

Borrowings of revolving credit facilities, net

224

107

Principal repayment of long-term debt

(471 )

(1,916 )

 

 

Net cash provided by (used in) financing activities

4,650

(1,809)

 

 

Effect of exchange rate on cash

(31)

36

 

 

Net change in cash and equivalents

3,574

(3,812)

Cash and equivalents at beginning of year

1,811

4,478

 

 

Cash and equivalents at end of period

$ 5,385

$ 666

 

 

Supplemental cash flow information:

Cash paid for interest

$ 281

$ 486

Cash paid for income tax

15

-

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTPGGAUUUPGGMQ
Date   Source Headline
16th Dec 20217:00 amRNSSale of ProPhotonix and cancelation of AIM Listing
17th Nov 20217:00 amRNSNotice of GM
11th Nov 202111:05 amRNSSecond Price Monitoring Extn
11th Nov 202111:00 amRNSPrice Monitoring Extension
11th Nov 20217:00 amRNSProPhotonix Announces Merger Agreement
2nd Nov 20217:00 amRNSProPhotonix Extends COBRA HyperSpec range
14th Sep 20217:00 amRNSProPhotonix announces the new UV COBRA Cure FX4
8th Sep 20217:00 amRNS2021 Half-year Report
9th Jun 20217:00 amRNSPosting of Annual Report and Accounts
2nd Jun 20217:00 amRNSNew Wavelengths added to UVC LED System
25th Mar 20217:00 amRNSResults for the year ended December 31, 2020
26th Jan 20217:00 amRNSNew Hyperspectral COBRA MultiSpec LED Line Light
16th Nov 20202:05 pmRNSSecond Price Monitoring Extn
16th Nov 20202:00 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSAdmission of Shares
10th Nov 20207:00 amRNSProPhotonix introduces 265nm UVC LED Lamp
9th Nov 20204:45 pmRNSResult of AGM and Director / PDMR Shareholdings
9th Oct 20207:00 amRNSPOSTING OF NOTICE OF ANNUAL GENERAL MEETING
8th Oct 20207:00 amRNSNew RGB-IR & RGB-White COBRA MultiSpec Line Lights
7th Oct 20203:07 pmRNSHolding(s) in Company
10th Sep 20207:00 amRNSINTERIM RESULTS FOR HALF YEAR ENDED JUNE 30, 2020
3rd Sep 20204:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:35 pmRNSPrice Monitoring Extension
3rd Sep 20202:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20202:00 pmRNSPrice Monitoring Extension
2nd Sep 20207:00 amRNSPROdigii Digital Lasers Range - 5 New Wavelengths
27th Aug 20207:00 amRNSRESULTS FOR THE YEAR ENDED DECEMBER 31, 2019
25th Aug 20201:47 pmRNSNOTICE OF EXTENSION OF RIGHTS PLAN
24th Jul 20207:00 amRNSHolding(s) in Company
16th Jul 20207:00 amRNSChange of Adviser and Director Disclosures
29th Jun 20207:00 amRNSCustom LED Backlight wins VSD Innovators Award
23rd Jun 20207:00 amRNSAccounts Reporting Extension & Trading Update
30th Apr 20207:00 amRNSDirectorate Change
9th Apr 20207:00 amRNSCOVID – 19 and Trading Update
19th Mar 20207:00 amRNS3 Year Framework Product Supply & IP Agreement
16th Mar 20207:00 amRNSProPhotonix - UV LED Water Disinfection
16th Jan 20207:00 amRNSTrading Update 2019
26th Nov 20197:00 amRNSHolding(s) in Company
10th Oct 20197:00 amRNS5-Year Master Purchase Agreement - Fortune 50 CGLM
12th Sep 20197:00 amRNSProPhotonix to Exhibit UV Lamps at Labelexpo 2019
6th Sep 20197:00 amRNSProPhotonix issues Half-year Report
3rd Sep 20197:00 amRNSNew High-Powered Red Laser Diode from Ushio
31st May 201911:59 amRNSProPhotonix Notification of Major Holdings
31st May 201911:58 amRNSProPhotonix Notification of Major Holdings
24th May 20197:00 amRNSPPIX Issues Director/PDMR Shareholding Notice
23rd May 20197:00 amRNSPPIX Issues Director/PDMR Shareholding Notice
17th May 20197:00 amRNSProPhotonix Announces Trading Update
16th May 20195:58 pmRNSPPIX Announces AGM Results and PDMR Shareholdings
16th May 20197:00 amRNSPPIX Offers New COBRA Cure Mini UV Curing System
9th Apr 20197:00 amRNSProPhotonix Honored by Vision Systems Design 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.